mdxhealth

mdxhealth mdxhealth MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies.

MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) markets of Brussels and Amsterdam under the ticker symbol "MDXH". Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.

A negative biopsy doesn’t always mean no cancer. Confirm mdx helps identify men at risk of clinically significant prosta...
15/09/2025

A negative biopsy doesn’t always mean no cancer. Confirm mdx helps identify men at risk of clinically significant prostate cancer, even after a negative result — reducing unnecessary repeat biopsies and delays in care. Learn more: https://ow.ly/k7t250Wrxx4

10/09/2025

In September, we wear blue to bring awareness to the dangers of prostate cancer and the benefits of prevention and early diagnosis. Join us this week, by sharing a photo of yourself wearing blue to show support and honor those affected by prostate cancer.

It’s Prostate Cancer Awareness Month. Have you talked to your doctor about your risk?Men over 50—or over 45 with a famil...
09/09/2025

It’s Prostate Cancer Awareness Month. Have you talked to your doctor about your risk?
Men over 50—or over 45 with a family history or African ancestry—should be having that conversation. Early detection saves lives. https://ow.ly/sjAJ50Wrxvc

We’re celebrating in style! We wear blue to increase awareness of prostate cancer prevalence and the benefits of early...
05/09/2025

We’re celebrating in style! We wear blue to increase awareness of prostate cancer prevalence and the benefits of early detection and diagnosis! How are you spreading awareness? https://ow.ly/WKEn50WrxAf

September is National Prostate Cancer Awareness Month – a key time to bring attention to the disease that affects thousa...
03/09/2025

September is National Prostate Cancer Awareness Month – a key time to bring attention to the disease that affects thousands of men and families each year. This year alone, over 313,780 men will be diagnosed and more than 35,770 will die from prostate cancer. Here at mdxhealth, we are dedicated to raising awareness and improving patient outcomes for those at-risk for the disease. https://ow.ly/aaox50Wrxr6

1 in 8 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is one of the most common cancers i...
01/09/2025

1 in 8 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is one of the most common cancers in men—but early detection can make all the difference. This , mdxhealth stands with patients, providers, and families in the fight for earlier, smarter care. https://ow.ly/8QqC50Wrxlk

Michael K. McGarrity, CEO, has been featured in the Orange County Business Journal! The article highlights two important...
26/08/2025

Michael K. McGarrity, CEO, has been featured in the Orange County Business Journal! The article highlights two important milestones for our company: achieving our first operating profit and the pending acquisition of the ExoDx Prostate Test, both of which strengthen our commitment to advancing precision prostate cancer diagnostics. Read the full article here: https://ow.ly/GkRR50WMq2x

At mdx, we’re transforming prostate cancer care with precision diagnostics that go beyond PSA and biopsy results. From e...
26/08/2025

At mdx, we’re transforming prostate cancer care with precision diagnostics that go beyond PSA and biopsy results. From early detection to treatment decision-making — we’re with you at every step. www.mdxhealth.com/tests

A negative prostate biopsy doesn’t always mean no cancer. Confirm mdx detects molecular changes in benign tissue to iden...
20/08/2025

A negative prostate biopsy doesn’t always mean no cancer. Confirm mdx detects molecular changes in benign tissue to identify men who may still be at risk.
• Reduce unnecessary repeat biopsies
• Identify patients who need closer follow-up
• Improve long-term outcomes

https://ow.ly/Azsg50Wrxeh

Chronic UTI symptoms with no clear answer? Our Resolve mdx test can identify bacteria missed by standard cultures — givi...
15/08/2025

Chronic UTI symptoms with no clear answer? Our Resolve mdx test can identify bacteria missed by standard cultures — giving patients and providers the clarity they’ve been searching for. https://ow.ly/v2Cm50Wrx9R

We’re excited to announce the pending acquisition of the ExoDx Prostate Test! This addition strengthens our commitment t...
12/08/2025

We’re excited to announce the pending acquisition of the ExoDx Prostate Test! This addition strengthens our commitment to advancing Mdx’s precision prostate cancer diagnostics — from risk assessment to diagnosis and treatment decisions.

We believe the addition of ExoDx offers an accurate, non-invasive, NO DRE solution and will provide enhanced clinical value to your patients and practice. Together, we're expanding access to better answers — and better outcomes. Learn more: https://ow.ly/4NvK50WEMW2

Address


Telephone

+18662595644

Website

Alerts

Be the first to know and let us send you an email when mdxhealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram